1
![Evofem Biosciences]()
![Evofem Biosciences]()
![Evofem Biosciences]()
Evofem Biosciences
Leadership team
Ms. Saundra Pelletier (Interim Chair, Pres & CEO)
Mr. Justin J. File (CFO & Sec.)
Ms. Amy Raskopf (Sr. VP of Investor Relations)
Products/ Services
Biopharma, Health Care, Medical, Women's
Number of Employees
100 - 500
Headquarters
San Diego, California, United States
Established
2009
Company Registration
SEC CIK number: 0001618835
Revenue
5M - 20M
Overview
Location
Summary
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.
History
Evofem Biosciences was founded in 2000 by Dr.Maria Fama. It is headquartered in La Jolla, California and has affiliate in San Diego, California.
Mission
Our mission is to provide women with innovative, safe, and effective products for their sexual and reproductive health.
Vision
Our vision is to improve the health and lifestyle of women everywhere by leveraging the latest medical advances in women's healthcare.
Key Team
Kathy Gallo-Doyle (VP of Sales)
Ms. Karina M. Fedasz (Head of Bus. Devel.)
Ms. Katherine Atkinson (Chief Commercial Officer)
Recognition and Awards
Evofem Biosciences has received numerous awards, including Frost & Sullivan’s USA Woman in Healthcare New Product Innovation Award and the United Nations’ Innovation in Women’s Health Award.
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Leadership team
Ms. Saundra Pelletier (Interim Chair, Pres & CEO)
Mr. Justin J. File (CFO & Sec.)
Ms. Amy Raskopf (Sr. VP of Investor Relations)
Products/ Services
Biopharma, Health Care, Medical, Women's
Number of Employees
100 - 500
Headquarters
San Diego, California, United States
Established
2009
Company Registration
SEC CIK number: 0001618835
Revenue
5M - 20M